DENIZ AKTAS: Open Payments
NPI 1023584588 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,989 in 212 payments from 19 companies in 2025. Trend: 2023 $2,861 · 2024 $3,592 · 2025 $3,989
Food & beverage: $3,989
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 73 | $1,338 |
| Lundbeck LLC | 24 | $425 |
| PFIZER INC. | 26 | $341 |
| Teva Pharmaceuticals USA, Inc. | 12 | $258 |
| Neurocrine BioSciences, Inc. | 13 | $253 |
| Merz Pharmaceuticals, LLC | 11 | $232 |
| SK Life Science, Inc. | 8 | $182 |
| Eisai Inc. | 9 | $177 |
| ARGENX US, INC. | 5 | $125 |
| TG Therapeutics, Inc. | 6 | $118 |
Products named: QULIPTA, VYEPTI, NURTEC ODT, UBRELVY, BOTOX, INGREZZA, INBRIJA, Leqembi.
Industry payments across OK — which companies pay providers there.
